Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "ctDNA Dynamics & Survival Outcomes in Pts with aNSCLC and High (>50%) PD-L1 Expression Randomized to Cemiplimab vs. Chemo"

147 views
June 21, 2023
Comments 0
Login to view comments. Click here to Login